KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Debt Ratio (2016 - 2025)

Jazz Pharmaceuticals has reported Debt Ratio over the past 16 years, most recently at 0.46 for Q4 2025.

  • Quarterly Debt Ratio fell 9.63% to 0.46 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.46 through Dec 2025, down 9.63% year-over-year, with the annual reading at 0.46 for FY2025, 9.63% down from the prior year.
  • Debt Ratio was 0.46 for Q4 2025 at Jazz Pharmaceuticals, down from 0.47 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.55 in Q3 2022 and troughed at 0.31 in Q1 2021.
  • The 5-year median for Debt Ratio is 0.5 (2021), against an average of 0.49.
  • Biggest five-year swings in Debt Ratio: skyrocketed 64.55% in 2022 and later decreased 9.63% in 2025.
  • Tracing JAZZ's Debt Ratio over 5 years: stood at 0.49 in 2021, then grew by 7.4% to 0.53 in 2022, then fell by 5.09% to 0.5 in 2023, then increased by 1.42% to 0.51 in 2024, then decreased by 9.63% to 0.46 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.46, 0.47, and 0.49 for Q4 2025, Q3 2025, and Q2 2025 respectively.